OpenVSafe by OpenVAERS
Search V-safe

8VX-27613-05305

3 vaccinations 1 coded response 18 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
241 / VA
Registered
2021-04-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Dose 1 — Moderna
  2. 2021-04-22
    Registered in v-safe
  3. 2021-04-22
    Dose 2 — Moderna
  4. 2021-04-22
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  6. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-10-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-11-29
    Dose 3 — Pfizer-BioNTech
  20. 2022-04-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-05-30
    Survey response — 6 months, dose 3
    MedDRA: Headache, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fevor, Headache and congestion
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-05-30
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  23. 2022-06-01
    Call successful
    Participant prefers to complete VAERS report online
  24. 2022-11-29
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Moderna
22021-04-22Moderna
32021-11-29Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 6 months, dose 3

2022-05-30

Symptoms: Fevor, Headache and congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…